Forward Pharma Operations ApS: Financial statements 2023
CVR: 38757504
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Forward Pharma Operations ApS (CVR 38757504) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 546,952 and a net result of DKK 1,043,207 compared with DKK -27,022,415 the year before. That is a decrease of 24.5% compared with the year before. The profit margin was 190.7%. Equity in the 2023 report amounted to DKK 279,126,138. The solvency ratio was 92.4%.
- Revenue
- DKK 546,952
- Gross Profit
- DKK -2,341,603
- Profit/Loss
- DKK 1,043,207
- Equity
- DKK 279,126,138
- Total Assets
- DKK 302,113,741
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 547 t. | -2.3 mio. | 1 mio. | 279.1 mio. | - |
| 2022 | 724 t. | -7.9 mio. | -27 mio. | 278.1 mio. | - |
| 2021 | 622 t. | -9 mio. | -9.5 mio. | 305.1 mio. | - |
| 2020 | 351 t. | -8.2 mio. | -10.1 mio. | 314.6 mio. | - |
| 2019 | 327 t. | -11.3 mio. | -7.5 mio. | 324.7 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Forward Pharma Operations ApS has published its annual report for 2022. Revenue came to DKK 724,020, and the net result was DKK -27,022,415.
As of June 8, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Forward Pharma Operations ApS.
As of June 8, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Forward Pharma Operations ApS.
About Forward Pharma Operations ApS
Forward Pharma Operations ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 30 October 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2024, the company reported revenue of DKK 99,127 and a net result of DKK -68,343,758 compared with DKK 1,043,207 the year before. Equity in the 2024 report amounted to DKK 280,041,147.